Global Influenza Medication Market Research Report 2026(Status and Outlook)
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
The global Influenza Medication market size was estimated at USD 3455.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Medication market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Medication market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Medication market.
Global Influenza Medication Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Market Segmentation (by Type)
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Market Segmentation (by Application)
Hospitals
Clinics
Pharmacies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Influenza Medication Market
Overview of the regional outlook of the Influenza Medication Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Medication Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Medication, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Influenza Medication market size was estimated at USD 3455.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Medication market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Medication market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Medication market.
Global Influenza Medication Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Market Segmentation (by Type)
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Market Segmentation (by Application)
Hospitals
Clinics
Pharmacies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Influenza Medication Market
Overview of the regional outlook of the Influenza Medication Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Medication Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Medication, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Medication
1.2 Key Market Segments
1.2.1 Influenza Medication Segment by Type
1.2.2 Influenza Medication Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA MEDICATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Medication Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Influenza Medication Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA MEDICATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Medication Product Life Cycle
3.3 Global Influenza Medication Sales by Manufacturers (2020-2025)
3.4 Global Influenza Medication Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Medication Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Medication Market Competitive Situation and Trends
3.8.1 Influenza Medication Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Medication Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA MEDICATION INDUSTRY CHAIN ANALYSIS
4.1 Influenza Medication Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA MEDICATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Medication Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Medication Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA MEDICATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Medication Sales Market Share by Type (2020-2025)
6.3 Global Influenza Medication Market Size by Type (2020-2025)
6.4 Global Influenza Medication Price by Type (2020-2025)
7 INFLUENZA MEDICATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Medication Market Sales by Application (2020-2025)
7.3 Global Influenza Medication Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Medication Sales Growth Rate by Application (2020-2025)
8 INFLUENZA MEDICATION MARKET SALES BY REGION
8.1 Global Influenza Medication Sales by Region
8.1.1 Global Influenza Medication Sales by Region
8.1.2 Global Influenza Medication Sales Market Share by Region
8.2 Global Influenza Medication Market Size by Region
8.2.1 Global Influenza Medication Market Size by Region
8.2.2 Global Influenza Medication Market Size by Region
8.3 North America
8.3.1 North America Influenza Medication Sales by Country
8.3.2 North America Influenza Medication Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Medication Sales by Country
8.4.2 Europe Influenza Medication Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Medication Sales by Region
8.5.2 Asia Pacific Influenza Medication Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Medication Sales by Country
8.6.2 South America Influenza Medication Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Medication Sales by Region
8.7.2 Middle East and Africa Influenza Medication Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA MEDICATION MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Medication by Region(2020-2025)
9.2 Global Influenza Medication Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Medication Production
9.4.1 North America Influenza Medication Production Growth Rate (2020-2025)
9.4.2 North America Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Medication Production
9.5.1 Europe Influenza Medication Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Medication Production (2020-2025)
9.6.1 Japan Influenza Medication Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Medication Production (2020-2025)
9.7.1 China Influenza Medication Production Growth Rate (2020-2025)
9.7.2 China Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Daiichi Sankyo Company
10.1.1 Daiichi Sankyo Company Basic Information
10.1.2 Daiichi Sankyo Company Influenza Medication Product Overview
10.1.3 Daiichi Sankyo Company Influenza Medication Product Market Performance
10.1.4 Daiichi Sankyo Company Business Overview
10.1.5 Daiichi Sankyo Company SWOT Analysis
10.1.6 Daiichi Sankyo Company Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Basic Information
10.2.2 GlaxoSmithKline Influenza Medication Product Overview
10.2.3 GlaxoSmithKline Influenza Medication Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 Natco Pharma
10.3.1 Natco Pharma Basic Information
10.3.2 Natco Pharma Influenza Medication Product Overview
10.3.3 Natco Pharma Influenza Medication Product Market Performance
10.3.4 Natco Pharma Business Overview
10.3.5 Natco Pharma SWOT Analysis
10.3.6 Natco Pharma Recent Developments
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Basic Information
10.4.2 F. Hoffmann-La Roche Influenza Medication Product Overview
10.4.3 F. Hoffmann-La Roche Influenza Medication Product Market Performance
10.4.4 F. Hoffmann-La Roche Business Overview
10.4.5 F. Hoffmann-La Roche Recent Developments
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Basic Information
10.5.2 Teva Pharmaceutical Influenza Medication Product Overview
10.5.3 Teva Pharmaceutical Influenza Medication Product Market Performance
10.5.4 Teva Pharmaceutical Business Overview
10.5.5 Teva Pharmaceutical Recent Developments
10.6 Sandoz International
10.6.1 Sandoz International Basic Information
10.6.2 Sandoz International Influenza Medication Product Overview
10.6.3 Sandoz International Influenza Medication Product Market Performance
10.6.4 Sandoz International Business Overview
10.6.5 Sandoz International Recent Developments
10.7 Sun Pharmaceutical Industries
10.7.1 Sun Pharmaceutical Industries Basic Information
10.7.2 Sun Pharmaceutical Industries Influenza Medication Product Overview
10.7.3 Sun Pharmaceutical Industries Influenza Medication Product Market Performance
10.7.4 Sun Pharmaceutical Industries Business Overview
10.7.5 Sun Pharmaceutical Industries Recent Developments
10.8 Mylan
10.8.1 Mylan Basic Information
10.8.2 Mylan Influenza Medication Product Overview
10.8.3 Mylan Influenza Medication Product Market Performance
10.8.4 Mylan Business Overview
10.8.5 Mylan Recent Developments
11 INFLUENZA MEDICATION MARKET FORECAST BY REGION
11.1 Global Influenza Medication Market Size Forecast
11.2 Global Influenza Medication Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Medication Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Medication Market Size Forecast by Region
11.2.4 South America Influenza Medication Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Medication by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Influenza Medication Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Influenza Medication by Type (2026-2035)
12.1.2 Global Influenza Medication Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Influenza Medication by Type (2026-2035)
12.2 Global Influenza Medication Market Forecast by Application (2026-2035)
12.2.1 Global Influenza Medication Sales (K MT) Forecast by Application
12.2.2 Global Influenza Medication Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Medication
1.2 Key Market Segments
1.2.1 Influenza Medication Segment by Type
1.2.2 Influenza Medication Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA MEDICATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Medication Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Influenza Medication Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA MEDICATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Medication Product Life Cycle
3.3 Global Influenza Medication Sales by Manufacturers (2020-2025)
3.4 Global Influenza Medication Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Medication Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Medication Market Competitive Situation and Trends
3.8.1 Influenza Medication Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Medication Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA MEDICATION INDUSTRY CHAIN ANALYSIS
4.1 Influenza Medication Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA MEDICATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Medication Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Medication Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA MEDICATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Medication Sales Market Share by Type (2020-2025)
6.3 Global Influenza Medication Market Size by Type (2020-2025)
6.4 Global Influenza Medication Price by Type (2020-2025)
7 INFLUENZA MEDICATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Medication Market Sales by Application (2020-2025)
7.3 Global Influenza Medication Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Medication Sales Growth Rate by Application (2020-2025)
8 INFLUENZA MEDICATION MARKET SALES BY REGION
8.1 Global Influenza Medication Sales by Region
8.1.1 Global Influenza Medication Sales by Region
8.1.2 Global Influenza Medication Sales Market Share by Region
8.2 Global Influenza Medication Market Size by Region
8.2.1 Global Influenza Medication Market Size by Region
8.2.2 Global Influenza Medication Market Size by Region
8.3 North America
8.3.1 North America Influenza Medication Sales by Country
8.3.2 North America Influenza Medication Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Medication Sales by Country
8.4.2 Europe Influenza Medication Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Medication Sales by Region
8.5.2 Asia Pacific Influenza Medication Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Medication Sales by Country
8.6.2 South America Influenza Medication Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Medication Sales by Region
8.7.2 Middle East and Africa Influenza Medication Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA MEDICATION MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Medication by Region(2020-2025)
9.2 Global Influenza Medication Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Medication Production
9.4.1 North America Influenza Medication Production Growth Rate (2020-2025)
9.4.2 North America Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Medication Production
9.5.1 Europe Influenza Medication Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Medication Production (2020-2025)
9.6.1 Japan Influenza Medication Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Medication Production (2020-2025)
9.7.1 China Influenza Medication Production Growth Rate (2020-2025)
9.7.2 China Influenza Medication Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Daiichi Sankyo Company
10.1.1 Daiichi Sankyo Company Basic Information
10.1.2 Daiichi Sankyo Company Influenza Medication Product Overview
10.1.3 Daiichi Sankyo Company Influenza Medication Product Market Performance
10.1.4 Daiichi Sankyo Company Business Overview
10.1.5 Daiichi Sankyo Company SWOT Analysis
10.1.6 Daiichi Sankyo Company Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Basic Information
10.2.2 GlaxoSmithKline Influenza Medication Product Overview
10.2.3 GlaxoSmithKline Influenza Medication Product Market Performance
10.2.4 GlaxoSmithKline Business Overview
10.2.5 GlaxoSmithKline SWOT Analysis
10.2.6 GlaxoSmithKline Recent Developments
10.3 Natco Pharma
10.3.1 Natco Pharma Basic Information
10.3.2 Natco Pharma Influenza Medication Product Overview
10.3.3 Natco Pharma Influenza Medication Product Market Performance
10.3.4 Natco Pharma Business Overview
10.3.5 Natco Pharma SWOT Analysis
10.3.6 Natco Pharma Recent Developments
10.4 F. Hoffmann-La Roche
10.4.1 F. Hoffmann-La Roche Basic Information
10.4.2 F. Hoffmann-La Roche Influenza Medication Product Overview
10.4.3 F. Hoffmann-La Roche Influenza Medication Product Market Performance
10.4.4 F. Hoffmann-La Roche Business Overview
10.4.5 F. Hoffmann-La Roche Recent Developments
10.5 Teva Pharmaceutical
10.5.1 Teva Pharmaceutical Basic Information
10.5.2 Teva Pharmaceutical Influenza Medication Product Overview
10.5.3 Teva Pharmaceutical Influenza Medication Product Market Performance
10.5.4 Teva Pharmaceutical Business Overview
10.5.5 Teva Pharmaceutical Recent Developments
10.6 Sandoz International
10.6.1 Sandoz International Basic Information
10.6.2 Sandoz International Influenza Medication Product Overview
10.6.3 Sandoz International Influenza Medication Product Market Performance
10.6.4 Sandoz International Business Overview
10.6.5 Sandoz International Recent Developments
10.7 Sun Pharmaceutical Industries
10.7.1 Sun Pharmaceutical Industries Basic Information
10.7.2 Sun Pharmaceutical Industries Influenza Medication Product Overview
10.7.3 Sun Pharmaceutical Industries Influenza Medication Product Market Performance
10.7.4 Sun Pharmaceutical Industries Business Overview
10.7.5 Sun Pharmaceutical Industries Recent Developments
10.8 Mylan
10.8.1 Mylan Basic Information
10.8.2 Mylan Influenza Medication Product Overview
10.8.3 Mylan Influenza Medication Product Market Performance
10.8.4 Mylan Business Overview
10.8.5 Mylan Recent Developments
11 INFLUENZA MEDICATION MARKET FORECAST BY REGION
11.1 Global Influenza Medication Market Size Forecast
11.2 Global Influenza Medication Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Medication Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Medication Market Size Forecast by Region
11.2.4 South America Influenza Medication Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Medication by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Influenza Medication Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Influenza Medication by Type (2026-2035)
12.1.2 Global Influenza Medication Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Influenza Medication by Type (2026-2035)
12.2 Global Influenza Medication Market Forecast by Application (2026-2035)
12.2.1 Global Influenza Medication Sales (K MT) Forecast by Application
12.2.2 Global Influenza Medication Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza Medication Market Size by Type (M USD)
Table 4. Global Influenza Medication Market Size by Application
Table 5. Influenza Medication Market Size Comparison by Region (M USD)
Table 6. Global Influenza Medication Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Influenza Medication Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza Medication Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza Medication Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Medication as of 2025)
Table 11. Global Market Influenza Medication Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Medication Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Influenza Medication Sales by Type (K MT)
Table 27. Global Influenza Medication Market Size by Type (M USD)
Table 28. Global Influenza Medication Sales (K MT) by Type (2020-2025)
Table 29. Global Influenza Medication Sales Market Share by Type (2020-2025)
Table 30. Global Influenza Medication Market Size (M USD) by Type (2020-2025)
Table 31. Global Influenza Medication Market Share by Type (2020-2025)
Table 32. Global Influenza Medication Price (USD/KG) by Type (2020-2025)
Table 33. Global Influenza Medication Sales (K MT) by Application
Table 34. Global Influenza Medication Market Size by Application
Table 35. Global Influenza Medication Sales by Application (2020-2025) & (K MT)
Table 36. Global Influenza Medication Sales Market Share by Application (2020-2025)
Table 37. Global Influenza Medication Market Size by Application (2020-2025) & (M USD)
Table 38. Global Influenza Medication Market Share by Application (2020-2025)
Table 39. Global Influenza Medication Sales Growth Rate by Application (2020-2025)
Table 40. Global Influenza Medication Sales by Region (2020-2025) & (K MT)
Table 41. Global Influenza Medication Sales Market Share by Region (2020-2025)
Table 42. Global Influenza Medication Market Size by Region (2020-2025) & (M USD)
Table 43. Global Influenza Medication Market Size by Region (2020-2025)
Table 44. North America Influenza Medication Sales by Country (2020-2025) & (K MT)
Table 45. North America Influenza Medication Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Influenza Medication Sales by Country (2020-2025) & (K MT)
Table 47. Europe Influenza Medication Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Influenza Medication Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Influenza Medication Market Size by Region (2020-2025) & (M USD)
Table 50. South America Influenza Medication Sales by Country (2020-2025) & (K MT)
Table 51. South America Influenza Medication Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Influenza Medication Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Influenza Medication Market Size by Region (2020-2025) & (M USD)
Table 54. Global Influenza Medication Production (K MT) by Region(2020-2025)
Table 55. Global Influenza Medication Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Influenza Medication Revenue Market Share by Region (2020-2025)
Table 57. Global Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Daiichi Sankyo Company Basic Information
Table 63. Daiichi Sankyo Company Influenza Medication Product Overview
Table 64. Daiichi Sankyo Company Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Daiichi Sankyo Company Business Overview
Table 66. Daiichi Sankyo Company SWOT Analysis
Table 67. Daiichi Sankyo Company Recent Developments
Table 68. GlaxoSmithKline Basic Information
Table 69. GlaxoSmithKline Influenza Medication Product Overview
Table 70. GlaxoSmithKline Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline SWOT Analysis
Table 73. GlaxoSmithKline Recent Developments
Table 74. Natco Pharma Basic Information
Table 75. Natco Pharma Influenza Medication Product Overview
Table 76. Natco Pharma Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Natco Pharma Business Overview
Table 78. Natco Pharma SWOT Analysis
Table 79. Natco Pharma Recent Developments
Table 80. F. Hoffmann-La Roche Basic Information
Table 81. F. Hoffmann-La Roche Influenza Medication Product Overview
Table 82. F. Hoffmann-La Roche Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. F. Hoffmann-La Roche Business Overview
Table 84. F. Hoffmann-La Roche Recent Developments
Table 85. Teva Pharmaceutical Basic Information
Table 86. Teva Pharmaceutical Influenza Medication Product Overview
Table 87. Teva Pharmaceutical Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceutical Business Overview
Table 89. Teva Pharmaceutical Recent Developments
Table 90. Sandoz International Basic Information
Table 91. Sandoz International Influenza Medication Product Overview
Table 92. Sandoz International Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sandoz International Business Overview
Table 94. Sandoz International Recent Developments
Table 95. Sun Pharmaceutical Industries Basic Information
Table 96. Sun Pharmaceutical Industries Influenza Medication Product Overview
Table 97. Sun Pharmaceutical Industries Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sun Pharmaceutical Industries Business Overview
Table 99. Sun Pharmaceutical Industries Recent Developments
Table 100. Mylan Basic Information
Table 101. Mylan Influenza Medication Product Overview
Table 102. Mylan Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Mylan Business Overview
Table 104. Mylan Recent Developments
Table 105. Global Influenza Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Influenza Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Influenza Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Influenza Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Influenza Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Influenza Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Influenza Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Influenza Medication Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Influenza Medication Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Influenza Medication Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Influenza Medication Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Influenza Medication Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Influenza Medication Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Influenza Medication Market Size by Type (M USD)
Table 4. Global Influenza Medication Market Size by Application
Table 5. Influenza Medication Market Size Comparison by Region (M USD)
Table 6. Global Influenza Medication Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Influenza Medication Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Influenza Medication Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Influenza Medication Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Medication as of 2025)
Table 11. Global Market Influenza Medication Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Medication Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Influenza Medication Sales by Type (K MT)
Table 27. Global Influenza Medication Market Size by Type (M USD)
Table 28. Global Influenza Medication Sales (K MT) by Type (2020-2025)
Table 29. Global Influenza Medication Sales Market Share by Type (2020-2025)
Table 30. Global Influenza Medication Market Size (M USD) by Type (2020-2025)
Table 31. Global Influenza Medication Market Share by Type (2020-2025)
Table 32. Global Influenza Medication Price (USD/KG) by Type (2020-2025)
Table 33. Global Influenza Medication Sales (K MT) by Application
Table 34. Global Influenza Medication Market Size by Application
Table 35. Global Influenza Medication Sales by Application (2020-2025) & (K MT)
Table 36. Global Influenza Medication Sales Market Share by Application (2020-2025)
Table 37. Global Influenza Medication Market Size by Application (2020-2025) & (M USD)
Table 38. Global Influenza Medication Market Share by Application (2020-2025)
Table 39. Global Influenza Medication Sales Growth Rate by Application (2020-2025)
Table 40. Global Influenza Medication Sales by Region (2020-2025) & (K MT)
Table 41. Global Influenza Medication Sales Market Share by Region (2020-2025)
Table 42. Global Influenza Medication Market Size by Region (2020-2025) & (M USD)
Table 43. Global Influenza Medication Market Size by Region (2020-2025)
Table 44. North America Influenza Medication Sales by Country (2020-2025) & (K MT)
Table 45. North America Influenza Medication Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Influenza Medication Sales by Country (2020-2025) & (K MT)
Table 47. Europe Influenza Medication Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Influenza Medication Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Influenza Medication Market Size by Region (2020-2025) & (M USD)
Table 50. South America Influenza Medication Sales by Country (2020-2025) & (K MT)
Table 51. South America Influenza Medication Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Influenza Medication Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Influenza Medication Market Size by Region (2020-2025) & (M USD)
Table 54. Global Influenza Medication Production (K MT) by Region(2020-2025)
Table 55. Global Influenza Medication Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Influenza Medication Revenue Market Share by Region (2020-2025)
Table 57. Global Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Influenza Medication Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Daiichi Sankyo Company Basic Information
Table 63. Daiichi Sankyo Company Influenza Medication Product Overview
Table 64. Daiichi Sankyo Company Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Daiichi Sankyo Company Business Overview
Table 66. Daiichi Sankyo Company SWOT Analysis
Table 67. Daiichi Sankyo Company Recent Developments
Table 68. GlaxoSmithKline Basic Information
Table 69. GlaxoSmithKline Influenza Medication Product Overview
Table 70. GlaxoSmithKline Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline SWOT Analysis
Table 73. GlaxoSmithKline Recent Developments
Table 74. Natco Pharma Basic Information
Table 75. Natco Pharma Influenza Medication Product Overview
Table 76. Natco Pharma Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Natco Pharma Business Overview
Table 78. Natco Pharma SWOT Analysis
Table 79. Natco Pharma Recent Developments
Table 80. F. Hoffmann-La Roche Basic Information
Table 81. F. Hoffmann-La Roche Influenza Medication Product Overview
Table 82. F. Hoffmann-La Roche Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. F. Hoffmann-La Roche Business Overview
Table 84. F. Hoffmann-La Roche Recent Developments
Table 85. Teva Pharmaceutical Basic Information
Table 86. Teva Pharmaceutical Influenza Medication Product Overview
Table 87. Teva Pharmaceutical Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceutical Business Overview
Table 89. Teva Pharmaceutical Recent Developments
Table 90. Sandoz International Basic Information
Table 91. Sandoz International Influenza Medication Product Overview
Table 92. Sandoz International Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Sandoz International Business Overview
Table 94. Sandoz International Recent Developments
Table 95. Sun Pharmaceutical Industries Basic Information
Table 96. Sun Pharmaceutical Industries Influenza Medication Product Overview
Table 97. Sun Pharmaceutical Industries Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sun Pharmaceutical Industries Business Overview
Table 99. Sun Pharmaceutical Industries Recent Developments
Table 100. Mylan Basic Information
Table 101. Mylan Influenza Medication Product Overview
Table 102. Mylan Influenza Medication Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Mylan Business Overview
Table 104. Mylan Recent Developments
Table 105. Global Influenza Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Influenza Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Influenza Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Influenza Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Influenza Medication Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Influenza Medication Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Influenza Medication Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Influenza Medication Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Influenza Medication Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Influenza Medication Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Influenza Medication Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Influenza Medication Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Influenza Medication Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Influenza Medication Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Medication
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Medication Market Size (M USD), 2025-2035
Figure 5. Global Influenza Medication Market Size (M USD) (2020-2035)
Figure 6. Global Influenza Medication Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Medication Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Medication Product Life Cycle
Figure 13. Influenza Medication Sales Share by Manufacturers in 2025
Figure 14. Global Influenza Medication Revenue Share by Manufacturers in 2025
Figure 15. Influenza Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Influenza Medication Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Medication Revenue in 2025
Figure 18. Industry Chain Map of Influenza Medication
Figure 19. Global Influenza Medication Market PEST Analysis
Figure 20. Global Influenza Medication Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Medication Market Share by Type
Figure 27. Sales Market Share of Influenza Medication by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Medication by Type in 2025
Figure 29. Market Share of Influenza Medication by Type (2020-2025)
Figure 30. Market Share of Influenza Medication by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Medication Market Share by Application
Figure 33. Global Influenza Medication Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Medication Sales Market Share by Application in 2025
Figure 35. Global Influenza Medication Market Share by Application (2020-2025)
Figure 36. Global Influenza Medication Market Share by Application in 2025
Figure 37. Global Influenza Medication Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Medication Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Medication Market Size by Region (2020-2025)
Figure 40. North America Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Medication Sales Market Share by Country in 2024
Figure 43. North America Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Medication Market Size by Country in 2024
Figure 45. U.S. Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Medication Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Medication Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Medication Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Medication Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Medication Sales Market Share by Country in 2024
Figure 53. Europe Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Medication Market Size by Country in 2024
Figure 55. Germany Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Medication Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Medication Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Medication Market Size by Region in 2024
Figure 68. China Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Medication Sales and Growth Rate (K MT)
Figure 79. South America Influenza Medication Sales Market Share by Country in 2024
Figure 80. South America Influenza Medication Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Medication Market Size by Country in 2024
Figure 82. Brazil Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Medication Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Medication Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Medication Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Medication Market Size by Region in 2024
Figure 92. Saudi Arabia Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Medication Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Medication Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Influenza Medication Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Influenza Medication Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Influenza Medication Market Share Forecast by Type (2026-2035)
Figure 111. Global Influenza Medication Sales Forecast by Application (2026-2035)
Figure 112. Global Influenza Medication Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Influenza Medication
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Medication Market Size (M USD), 2025-2035
Figure 5. Global Influenza Medication Market Size (M USD) (2020-2035)
Figure 6. Global Influenza Medication Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Medication Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Medication Product Life Cycle
Figure 13. Influenza Medication Sales Share by Manufacturers in 2025
Figure 14. Global Influenza Medication Revenue Share by Manufacturers in 2025
Figure 15. Influenza Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Influenza Medication Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Medication Revenue in 2025
Figure 18. Industry Chain Map of Influenza Medication
Figure 19. Global Influenza Medication Market PEST Analysis
Figure 20. Global Influenza Medication Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Medication Market Share by Type
Figure 27. Sales Market Share of Influenza Medication by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Medication by Type in 2025
Figure 29. Market Share of Influenza Medication by Type (2020-2025)
Figure 30. Market Share of Influenza Medication by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Medication Market Share by Application
Figure 33. Global Influenza Medication Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Medication Sales Market Share by Application in 2025
Figure 35. Global Influenza Medication Market Share by Application (2020-2025)
Figure 36. Global Influenza Medication Market Share by Application in 2025
Figure 37. Global Influenza Medication Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Medication Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Medication Market Size by Region (2020-2025)
Figure 40. North America Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Medication Sales Market Share by Country in 2024
Figure 43. North America Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Medication Market Size by Country in 2024
Figure 45. U.S. Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Medication Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Medication Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Medication Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Medication Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Medication Sales Market Share by Country in 2024
Figure 53. Europe Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Medication Market Size by Country in 2024
Figure 55. Germany Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Medication Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Medication Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Medication Market Size by Region in 2024
Figure 68. China Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Medication Sales and Growth Rate (K MT)
Figure 79. South America Influenza Medication Sales Market Share by Country in 2024
Figure 80. South America Influenza Medication Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Medication Market Size by Country in 2024
Figure 82. Brazil Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Medication Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Medication Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Medication Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Medication Market Size by Region in 2024
Figure 92. Saudi Arabia Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Medication Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Medication Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Medication Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Medication Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Medication Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Influenza Medication Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Influenza Medication Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Influenza Medication Market Share Forecast by Type (2026-2035)
Figure 111. Global Influenza Medication Sales Forecast by Application (2026-2035)
Figure 112. Global Influenza Medication Market Share Forecast by Application (2026-2035)
